A new drug molecule (IMOL 881) was synthesized and is showing interest
ing trypanocidal properties. test results on animal models indicate ac
tivity against several trypanosome species, both in the veterinary and
in the human medicine application fields. The species tested so far i
nclude: T. evansi, T. equiperdum, T. gambiense and T. rhodesiense. The
good activity combined with a relatively low toxicity results in a hi
gh therapeutic index (> 100). In addition to its curative properties,
the drug also seems to exhibit a prophylactic potential, as evidenced
by tests on drug treated mice, subsequently infected with T. evansi.